Thousands of Supplemental Nutrition Assistance Program (SNAP) recipients will keep their benefits for now after federal officials extended an exemption tied to new work requirements, delaying changes ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Note: Totals might not equal 100 because of rounding. Source: Section survey of 5,000 white-collar workers from companies with 1,000 or more people in the U.S., U.K. and Canada conducted Sept. 26-Nov.

An AI model that learns without human input—by posing interesting queries for itself—might point the way to superintelligence. Save this story Save this story Even the smartest artificial intelligence ...

I had at least one child home sick three out of five days this week. But because I can work remotely, it didn't dramatically throw my day off track. If I had to report to work in an office, however, I ...

Few ideas have gained more traction among leaders in recent years than the need for employee appreciation and recognition. In 2022, Gallup found that just 19% of senior leaders viewed employee ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Christopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals, recently sold a significant chunk of his company's common stock. The CEO of Recursion Pharmaceuticals recently disposed of 120 ...

The robots mimic the movements and body temperature of real rabbits, a favored prey of pythons. The project is funded by the South Florida Water Management District and builds upon previous research ...